Global Antihypertensive Drugs Market

1. Summary

The Global Antihypertensive Drugs Market was valued at $26.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 3.8% CAGR, to an estimated market size of $31.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global antihypertensive drugs market includes pharmacological treatments such as ACE inhibitors, ARBs, calcium channel blockers, and diuretics used to manage systemic hypertension and pulmonary arterial hypertension. The scope excludes lifestyle interventions, diagnostic monitoring devices, and drugs specifically for ocular hypertension.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Antihypertensive Drugs Market in the period 2025-30:

• The rising global prevalence of hypertension is driven by an aging geriatric population and increasingly sedentary lifestyles.
• There is a significant shift toward Fixed-Dose Combinations (FDCs) to simplify treatment regimens and improve patient adherence.
• The market faces pressure from patent expirations of blockbuster drugs, leading to an influx of low-cost generic alternatives.
• Integration of digital health solutions and AI-enabled platforms is enhancing remote patient monitoring and personalized treatment adjustments.
• Emerging markets in Asia-Pacific are seeing rapid growth due to urbanization and improved access to affordable medications.
• Advancements in personalized medicine are utilizing pharmacogenomics to tailor antihypertensive therapies to individual genetic profiles.
• The development of novel drug classes, such as endothelin receptor antagonists, is targeting treatment-resistant hypertension segments.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: